These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 39273272)

  • 21. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
    Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
    Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
    Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S
    Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models.
    Benedicto I; Dorado B; Andrés V
    Cells; 2021 May; 10(5):. PubMed ID: 34064612
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotype.
    Lee SJ; Jung YS; Yoon MH; Kang SM; Oh AY; Lee JH; Jun SY; Woo TG; Chun HY; Kim SK; Chung KJ; Lee HY; Lee K; Jin G; Na MK; Ha NC; Bárcena C; Freije JM; López-Otín C; Song GY; Park BJ
    J Clin Invest; 2016 Oct; 126(10):3879-3893. PubMed ID: 27617860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear envelope budding inhibition slows down progerin-induced aging process.
    Wang X; Ma L; Lu D; Zhao G; Ren H; Lin Q; Jia M; Huang F; Wang S; Xu Z; Yang Z; Chu Y; Xu Z; Li W; Yu L; Jiang Q; Zhang C
    Proc Natl Acad Sci U S A; 2024 Oct; 121(41):e2321378121. PubMed ID: 39352925
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Progeria-based vascular model identifies networks associated with cardiovascular aging and disease.
    Ngubo M; Chen Z; McDonald D; Karimpour R; Shrestha A; Yockell-Lelièvre J; Laurent A; Besong OTO; Tsai EC; Dilworth FJ; Hendzel MJ; Stanford WL
    Aging Cell; 2024 Jul; 23(7):e14150. PubMed ID: 38576084
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hutchinson-Gilford progeria patient-derived cardiomyocyte model of carrying LMNA gene variant c.1824 C > T.
    Perales S; Sigamani V; Rajasingh S; Czirok A; Rajasingh J
    Cell Tissue Res; 2023 Oct; 394(1):189-207. PubMed ID: 37572165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hutchinson-Gilford progeria syndrome through the lens of transcription.
    Prokocimer M; Barkan R; Gruenbaum Y
    Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody.
    McClintock D; Gordon LB; Djabali K
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2154-9. PubMed ID: 16461887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation of a Hutchinson-Gilford progeria syndrome monkey model by base editing.
    Wang F; Zhang W; Yang Q; Kang Y; Fan Y; Wei J; Liu Z; Dai S; Li H; Li Z; Xu L; Chu C; Qu J; Si C; Ji W; Liu GH; Long C; Niu Y
    Protein Cell; 2020 Nov; 11(11):809-824. PubMed ID: 32729022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
    Gabriel D; Roedl D; Gordon LB; Djabali K
    Aging Cell; 2015 Feb; 14(1):78-91. PubMed ID: 25510262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome.
    Beyret E; Liao HK; Yamamoto M; Hernandez-Benitez R; Fu Y; Erikson G; Reddy P; Izpisua Belmonte JC
    Nat Med; 2019 Mar; 25(3):419-422. PubMed ID: 30778240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy to gene editing: potential therapeutic approaches for Hutchinson-Gilford progeria syndrome.
    Saxena S; Kumar S
    Geroscience; 2020 Apr; 42(2):467-494. PubMed ID: 32048129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
    Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
    Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impaired end joining induces cardiac atrophy in a Hutchinson-Gilford progeria mouse model.
    Chen Y; Huang S; Cui Z; Sun X; Tang Y; Zhang H; Chen Z; Jiang R; Zhang W; Li X; Chen J; Liu B; Jiang Y; Wei K; Mao Z
    Proc Natl Acad Sci U S A; 2023 Nov; 120(47):e2309200120. PubMed ID: 37967221
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MG132-induced progerin clearance is mediated by autophagy activation and splicing regulation.
    Harhouri K; Navarro C; Depetris D; Mattei MG; Nissan X; Cau P; De Sandre-Giovannoli A; Lévy N
    EMBO Mol Med; 2017 Sep; 9(9):1294-1313. PubMed ID: 28674081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Permanent farnesylation of lamin A mutants linked to progeria impairs its phosphorylation at serine 22 during interphase.
    Moiseeva O; Lopes-Paciencia S; Huot G; Lessard F; Ferbeyre G
    Aging (Albany NY); 2016 Feb; 8(2):366-81. PubMed ID: 26922519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
    Brassard JA; Fekete N; Garnier A; Hoesli CA
    Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
    Lo Cicero A; Nissan X
    Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone dysplasia in Hutchinson-Gilford progeria syndrome is associated with dysregulated differentiation and function of bone cell populations.
    Cabral WA; Stephan C; Terajima M; Thaivalappil AA; Blanchard O; Tavarez UL; Narisu N; Yan T; Wincovitch SM; Taga Y; Yamauchi M; Kozloff KM; Erdos MR; Collins FS
    Aging Cell; 2023 Sep; 22(9):e13903. PubMed ID: 37365004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.